Clario Acquires AI Software Firm ArtiQ

 


Clario, a company that does healthcare research and technology, just announced that they bought another company called ArtiQ. This is a big deal because it means that Clario can use even more artificial intelligence (AI) in their Respiratory Solutions. They want to find new and innovative ways to use AI in their work.


The CEO of Clario, Chris Fikry, is really excited about this. He thinks that AI can make clinical trials better and faster. With ArtiQ's technology, they can use AI to read and analyze data more quickly. This will help patients all over the world who are in clinical trials.


Marko Topalovic, the leader of ArtiQ, will now be in charge of AI for the whole company. He thinks that joining Clario is a big moment for ArtiQ. Their technology will now be used in more clinical trials, which will help patients and improve the results of the trials.


Clario also bought another company called Inofab Health. They make devices that help with breathing tests. By bringing all of these companies together, Clario can make their Respiratory Solutions even better. They can also use AI in more clinical trials and help even more people in the healthcare industry.


More Informarionhttps://www.techdogs.com/tech-news/pr-newswire/clario-announces-acquisition-of-ai-powered-software-company-artiq

Comments

Popular posts from this blog

Aon Unveils $350M Program for Ukraine Recovery

TECNO CAMON 20 Premier 5G and PHANTOM V Flip 5G Secure German Design Awards 2024

Lion Energy Unveils 10W Solar Panel for Portable Power